Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-19 Sale |
2025-02-19 9:50 pm |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
2,215 | $57.22 | $126,742 | 233,879 (Direct) |
View |
| 2025-02-12 Sale |
2025-02-14 4:59 pm |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
751 | $56.39 | $42,347 | 105,544 (Direct) |
View |
| 2025-02-11 Sale |
2025-02-11 9:44 pm |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
1,296 | $57.51 | $74,533 | 110,357 (Direct) |
View |
| 2025-02-04 Sale |
2025-02-04 9:27 pm |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
1,678 | $59.43 | $99,724 | 111,036 (Direct) |
View |
| 2024-03-19 Sale |
2024-03-19 8:57 pm |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
15,515 | $39.22 | $608,498 | 97,939 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 8:50 pm |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
1,918 | $50.8 | $97,441 | 90,171 (Direct) |
View |
| 2024-02-01 Sale |
2024-02-05 6:54 pm |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
1,616 | $45.06 | $72,817 | 89,990 (Direct) |
View |
| 2023-12-05 Sale |
2023-12-07 4:16 pm |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
27,026 | $38.72 | $1,046,360 | 303,594 (Direct) |
View |
| 2023-11-24 Sale |
2023-11-28 4:05 pm |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
10,974 | $35.02 | $384,336 | 199,526 (Direct) |
View |
| 2023-11-14 Sale |
2023-11-16 4:05 pm |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
12,000 | $30.38 | $364,573 | 210,500 (Direct) |
View |
| 2023-02-14 Sale |
2023-02-14 8:59 pm |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
702 | $26.87 | $18,863 | 64,093 (Direct) |
View |
| 2023-02-09 Sale(A) |
2023-02-14 7:08 pm |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
1,413 | $27.51 | $38,872 | 57,764 (Direct) |
View |
| 2023-02-09 Sale |
2023-02-13 5:03 pm |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
1,398 | $27.66 | $38,669 | 69,966 (Direct) |
View |
| 2022-07-01 Sale |
2022-07-06 6:08 pm |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
7,547 | $4.08 | $30,792 | 57,614 (Direct) |
View |
| 2022-02-15 Sale |
2022-02-15 7:31 pm |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
833 | $6.1 | $5,081 | 47,192 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-14 Option Award |
2025-02-19 9:50 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
104,150 | $0 | 233,879 (Direct) |
View |
| 2025-02-16 Exercise |
2025-02-19 9:50 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
6,600 | $0 | 233,879 (Direct) |
View |
| 2025-02-09 Exercise |
2025-02-11 9:44 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
6,405 | $0 | 110,357 (Direct) |
View |
| 2025-02-01 Exercise |
2025-02-04 9:27 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
4,925 | $0 | 111,036 (Direct) |
View |
| 2024-02-16 Option Award |
2024-02-21 7:01 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
140,550 | $0 | 220,254 (Direct) |
View |
| 2024-02-09 Exercise |
2024-02-13 8:50 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
6,407 | $0 | 90,171 (Direct) |
View |
| 2024-02-01 Exercise |
2024-02-05 6:54 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
4,925 | $0 | 89,990 (Direct) |
View |
| 2023-12-29 Exercise |
2024-01-03 4:15 pm |
N/A 2027-08-08 |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
10,500 | $0 | 172,500 (Direct) |
View |
| 2023-12-29 Exercise |
2024-01-03 4:15 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
10,500 | $6.88 | 172,500 (Direct) |
View |
| 2023-12-05 Exercise |
2023-12-07 4:16 pm |
N/A 2027-08-08 |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
27,026 | $0 | 303,594 (Direct) |
View |
| 2023-12-05 Exercise |
2023-12-07 4:16 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
27,026 | $6.88 | 303,594 (Direct) |
View |
| 2023-11-24 Exercise |
2023-11-28 4:05 pm |
N/A 2027-08-08 |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
10,974 | $0 | 199,526 (Direct) |
View |
| 2023-11-24 Exercise |
2023-11-28 4:05 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
10,974 | $6.88 | 199,526 (Direct) |
View |
| 2023-11-14 Exercise |
2023-11-16 4:05 pm |
N/A 2027-08-08 |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
12,000 | $0 | 210,500 (Direct) |
View |
| 2023-11-14 Exercise |
2023-11-16 4:05 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
12,000 | $6.88 | 210,500 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-30 4:31 pm |
N/A 2033-06-22 |
Aeglea BioTherapeutics Inc. | AGLE | Smith Hunter C Director |
1,950,000 | $0 | 1,950,000 (Direct) |
View |
| 2023-06-16 Exercise |
2023-06-21 4:05 pm |
N/A 2027-08-08 |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
2,000 | $0 | 222,500 (Direct) |
View |
| 2023-06-16 Exercise |
2023-06-21 4:05 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
2,000 | $6.88 | 222,500 (Direct) |
View |
| 2023-02-11 Exercise |
2023-02-14 8:59 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
2,344 | $0 | 64,093 (Direct) |
View |
| 2023-02-09 Exercise |
2023-02-13 5:03 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
4,063 | $0 | 69,966 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:09 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
73,300 | $0 | 73,300 (Direct) |
View |
| 2022-12-23 Gift |
2022-12-29 4:31 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
2,500 | $0 | 55,114 (Direct) |
View |
| 2022-06-30 Exercise |
2022-07-06 6:08 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
25,000 | $0 | 57,614 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 9:19 pm |
N/A 2032-06-06 |
Aeglea BioTherapeutics Inc. | AGLE | Smith Hunter C Director |
43,000 | $0 | 43,000 (Direct) |
View |
| 2022-02-11 Exercise |
2022-02-15 7:31 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
2,344 | $0 | 47,192 (Direct) |
View |
| 2022-02-09 Option Award |
2022-02-11 9:35 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
113,750 | $0 | 113,750 (Direct) |
View |
| 2021-11-12 Option Award |
2021-11-16 4:34 pm |
N/A 2031-11-11 |
Aeglea BioTherapeutics Inc. | AGLE | Smith Hunter C Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2021-04-21 Exercise |
2021-04-23 06:08 am |
N/A 2027-08-08 |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
5,000 | $0 | 201,744 (Direct) |
View |
| 2021-04-21 Exercise |
2021-04-23 06:08 am |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
5,000 | $6.88 | 201,744 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 5:27 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
65,625 | $0 | 65,625 (Direct) |
View |
| 2021-01-19 Exercise |
2021-01-20 4:05 pm |
N/A 2027-08-08 |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
4,000 | $0 | 201,744 (Direct) |
View |
| 2021-01-19 Exercise |
2021-01-20 4:05 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
4,000 | $6.88 | 201,744 (Direct) |
View |
| 2020-07-20 Option Award |
2020-07-21 5:16 pm |
N/A 2030-07-19 |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C Chief Financial Officer |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-02 4:05 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS INC. | RYTM | Smith Hunter C CFO and Interim CEO |
25,000 | $0 | 25,000 (Direct) |
View |